Hoffmann-La Roche: all 2,744 studies
Page 28 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2CompletedNCT00005635Phase 2
- A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected PatientsCompletedNCT00002448Phase 3
- A Study to Compare Two Anti-HIV Drug CombinationsCompletedNCT00002447Phase 3
- The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV DrugsCompletedNCT00002425Phase 4
- A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney DiseaseCompletedNCT00002397Phase 3
- A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected PatientsCompletedNCT00002383Phase 1
- A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected PatientsCompletedNCT00002382Phase 3
- The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and ChildrenCompletedNCT00002380Phase 1
- A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected PatientsCompletedNCT00002378Phase 3
- A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the EyesCompletedNCT00002377Phase 3
- A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected PatientsCompletedNCT00002374Phase 3
- A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002367Phase 3
- A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous TreatmentCompletedNCT00002334Phase 3
- A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take ZidovudineCompletedNCT00002333Phase 2
- A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's SarcomaCompletedNCT00002314Phase 2
- The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSCompletedNCT00002299Not applicable
- A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)CompletedNCT00002279Not applicable
- A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDSCompletedNCT00002273Not applicable
- An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492CompletedNCT00002265Phase 2
- A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDSCompletedNCT00002257Not applicable
- Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.CompletedNCT00002256Not applicable
- A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral GanciclovirCompletedNCT00002251Not applicable
- A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic PurpuraCompletedNCT00002250Phase 1
- A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir TherapyCompletedNCT00002247Not applicable
- A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected AdultsCompletedNCT00002239Phase 2
- Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected PatientsCompletedNCT00002229Phase 4
- A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDSCompletedNCT00002222Not applicable
- A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected PatientsCompletedNCT00002190Phase 2
- A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive PatientsCompletedNCT00002178Phase 3
- A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral DrugsCompletedNCT00002162Phase 2
- Treatment of Psoriasis Using Acitretin in HIV-Positive PatientsCompletedNCT00002143Phase 3
- An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous AccessCompletedNCT00002135Not applicable
- An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical StudiesCompletedNCT00002118Not applicable
- A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV InfectionCompletedNCT00002117Phase 3
- A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and DidanosineCompletedNCT00002096Phase 1
- A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency VirusCompletedNCT00002095Not applicable
- Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV DiseaseCompletedNCT00002081Not applicable
- A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDSCompletedNCT00002034Not applicable
- Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised PatientCompletedNCT00002025Not applicable
- Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus InfectionsCompletedNCT00002024Not applicable
- A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related ComplexCompletedNCT00002005Not applicable
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related ComplexCompletedNCT00002004Phase 1
- A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult VolunteersCompletedNCT00001992Phase 1
- Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddCCompletedNCT00001040Phase 2